Pricing Log in Create free account
Friday 6 November 2026 Export GRAL’s income statement to Excel — free account

GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue
+3.71%
EPS
+10.2%
Free cash flow
−24.9%

Quarter to September 2026, against a year earlier

125.27 6.14 +5.15%
Market cap
$5.3B
P/E
0.0×
Fwd P/E
−14.5×
Dividend yield
—
F-score
6/9
Altman Z
0.37
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

GRAIL, Inc. (GRAL) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, GRAIL, Inc. (GRAL) trades at a EV/Sales of 29.8×. Over the past ten years it has ranged from −5.5× (September 2024) to 39.4× (October 2026); the current reading is higher than 96% of that period. That is above the Diagnostics & Research industry median of 5.2× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 15.2× —
FY2024 −1.5× —
FY2023 0.0× —
FY2022 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 34.2× 171.27%
Jun 2026 12.6× 53.97%
Mar 2026 8.2× (46.28%)
Dec 2025 15.2× 35.34%
9 more quarters

Against its own ten years

Low −5.5× High 39.4×
Ten-year median 6.0×
Current reading's percentile 96

EV/Sales against peers

Company EV/Sales
ICLR ICON PLC compare 2.4×
VCYT Veracyte, Inc. compare 2.5×
RDNT RadNet, Inc. compare 3.0×
SHC Sotera Health Company compare 5.2×
QGEN QIAGEN N.V. compare 5.4×
CDNA CareDx, Inc. compare 7.6×
BLLN BillionToOne, Inc. compare 11.0×
ADPT Adaptive Biotechnologies Corporation compare 14.6×
GRAL GRAIL, Inc. 29.8×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on GRAL